(Q37291349)

19 August 2017

1 reference

title

Multiresistant Enterobacteriaceae: new threat of an old problem (English)

1 reference

19 August 2017

main subject

multiple drug resistance

1 reference

0 references

Johann D D Pitout

1

1 reference

19 August 2017

publication date

1 October 2008

1 reference

Expert Review of Anti-infective Therapy

19 August 2017

published in

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

657-669

1 reference

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Resistance in gram-negative bacteria: Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

21 January 2018

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Mechanisms of resistance to quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Evolution of extended-spectrum beta-lactamases by mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

The continuing challenge of ESBLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

CTX-M: changing the face of ESBLs in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

The CTX-M beta-lactamase pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

The spread of CTX-M-type extended-spectrum beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Extended-spectrum beta-lactamases in long-term-care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

21 January 2018

Class A carbapenemases

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Carbapenemases: molecular diversity and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Metallo-beta-lactamases: the quiet before the storm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

AmpC beta-lactamases: what do we need to know for the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Plasmid-determined AmpC-type beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Detection of plasmid-mediated class C beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

The worldwide emergence of plasmid-mediated quinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Origin of plasmid-mediated quinolone resistance determinant QnrA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Multicenter antimicrobial susceptibility survey of gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Broader distribution of plasmid-mediated quinolone resistance in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Plasmid-mediated quinolone resistance in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Is plasmid-mediated quinolone resistance a clinically significant problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.657

21 January 2018

Identifiers

DOI

10.1586/14787210.6.5.657

1 reference

19 August 2017

1 reference